Global Orexin Receptor Type 2 Market Professional Survey Report 2019

SKU ID :QYR-14620646 | Published Date: 23-Oct-2019 | No. of pages: 104

The global Orexin Receptor Type 2 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Orexin Receptor Type 2 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Orexin Receptor Type 2 market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Orexin Receptor Type 2 in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Orexin Receptor Type 2 manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Actelion Pharmaceuticals Ltd
Eisai Co Ltd
Evotec AG
Heptares Therapeutics Ltd
Idorsia Ltd
Johnson & Johnson
Merck & Co Inc
OptiNose US Inc
Yangtze River Pharmaceutical Group

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
HTL-6641
MK-8133
Lemborexant
OPN-021
YNT-185
Others

Segment by Application
Insomnia
Narcolepsy
Sleep Disorders
Major Depressive Disorder
  • PRICE
  • $3500
    $7000
    Buy Now

Our Clients